patient, Weight loss
A doctor shares how his patients are trying to afford weight-loss drugs — and what happens if they can't
Drug companies are under fire for the high cost of Ozempic and simlar meds. A doctor said patients who can't afford it may get riskier online versions.
Weight-loss drugs are supposed to be forever. Until they run out.
Waibel went through two months’ worth of Wegovy before Waibel’s pharmacy ran out. All the CVS, Walgreens and Wegmans stores within a few hours’ drive from Waibel’s home in
Weight loss drugs like Ozempic and Wegovy are tremendously popular and effective. Patients should also be careful in using them
Semaglutide, the underlying drug marketed as Ozempic and Wegovy, works by mimicking a hormone that triggers the body to feel full. When the drug interacts with a receptor in the stomach, patients feel full sooner and for a longer period of time after eating. The drug does not cause weight loss directly – instead, it makes you want to eat less.
7 Mistakes People Make While Taking Weight Loss Drugs, According to Experts
GLP-1 medications—like Ozempic, Wegovy, and Zepbound—can help you shed pounds, but only if taken properly. Don't get caught making these semaglutide slip-ups.
Competition explodes amid weight loss drug shortage
Ongoing shortages of popular weight loss and diabetes drugs in the U.S. have spurred fierce competition between established drugmakers and an emerging market of compounded versions as telehealth
Congress pushes to lower the price of weight loss drugs
Congress is pushing companies like Ozempic and Wegovy, which make weight loss drugs that have changed the lives of millions of Americans, to lower their prices and make them more affordable to the masses.
'Fake weight loss drug nearly killed me'
Weight loss drugs have become popular due to social media and celebrities using them to shed excess pounds quickly. Although prescribed on the NHS for those who are obese or have Type 2 diabetes, they can be bought privately, with not all providers legitimate.
While brand-name weight loss drugs are in short supply, a market for alternatives thrives
High demand for weight-loss and diabetes drugs like Ozempic and Wegovy has led to a shortage in manufacturing. In the meantime, a market for cheaper, compounded drugs thrives.
WeightWatchers CEO who oversaw move into weight loss drugs abruptly leaves role
WW International announced Friday that CEO Sima Sistani would leave her role effective immediately. Tara Comonte, a WeightWatchers board member and former Shake Shack executive, was made interim chief executive.
WeightWatchers is struggling in the weight loss drug era — and now the CEO is out
International said Friday that CEO Sima Sistani is stepping down immediately. She will be replaced by Tara Comonte, a board member and the former CEO of Shake Shack (SHAK), who was appointed as interim chief executive effective immediately.
ABC News1d
WeightWatchers CEO who oversaw diet company's move into weight loss drugs abruptly leaves role
Sistani joined WeightWatchers as CEO more than two years ago. During her tenure, she led the company's recent moves into the ...
WeightWatchers CEO suddenly quits after push to embrace weight-loss drugs like Ozempic, Wegovy
Sima Sistani, who took up the CEO post at WW International two-and-a-half years ago, is out, according to the company.
WeightWatchers CEO Sima Sistani out in abrupt exit, embraced weight loss drugs
WeightWatchers announced Friday that CEO Sima Sistani is no longer at the company, and independent board member Tara Comonte ...
Weight-loss drugs are life-changing — and expensive. Here's one woman's solution.
A woman who started taking a popular weight loss medication through a clinical trial had to look for alternatives when her ...
Hosted on MSN55m
Weight-loss jabs reduce risk of some of the most deadly cancers
Revolutionary weight-loss injections such as Wegovy and Ozempic reduce the risk of some of the most common and deadly cancers, a major study suggests. Obese patients taking the drugs, which were ...
Prediction: Eli Lilly Will Dominate the Billion-Dollar Weight Loss Drug Market for This Key Reason
Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.
New weight loss drugs spark eating disorder concerns in teens
BOSTON - There is concern over the newest weight loss drugs sparking eating disorders in teens. Newer GLP-1 weight loss drugs ...
Early Study Shows Weight Loss Pill Amycretin May Lead to Significant Results Compared to Ozempic
The future of oral weight loss medication looks bright. Drug manufacturer Novo Nordisk announced a new experimental ...